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SUMMARY
The purpose of this study was to evaluate prospectively the accuracy of qualitative and strain ratio elastography (SE) in the differ-
ential diagnosis of non-palpable testicular lesions. The local review board approved the protocol and all patients gave their consent.
One hundred and six patients with non-palpable testicular lesions were consecutively enrolled. Baseline ultrasonography (US) and
SE were correlated with clinical and histological features and ROC curves developed for diagnostic accuracy. The non-palpable
lesions were all ≤1.5 cm; 37/106 (34.9%) were malignant, 38 (35.9%) were benign, and 31 (29.2%) were non-neoplastic. Independent
risk factors for malignancy were as follows: size (OR 17.788; p = 0.002), microlithiasis (OR 17.673, p < 0.001), intralesional vascular-
ization (OR 9.207, p = 0.006), and hypoechogenicity (OR, 11.509, p = 0.036). Baseline US had 89.2% sensitivity (95% CI 74.6–97.0)
and 85.5% specificity (95% CI 75.0–92.8) in identifying malignancies, and 94.6% sensitivity (95% CI 86.9–98.5) and 87.1% specificity
(95% CI 70.2–96.4) in discriminating neoplasms from non-neoplastic lesions. An elasticity score (ES) of 3 out of 3 (ES3, maximum
hardness) was recorded in 30/37 (81.1%) malignant lesions (p < 0.001). An intermediate score of 2 (ES2) was recorded in 19/38
(36.8%) benign neoplastic lesions and in 22/31 (71%) non-neoplastic lesions (p = 0.005 and p = 0.001 vs. malignancies). None of the
non-neoplastic lesions scored ES3. Logistic regression analysis revealed a significant association between ES3 and malignancy
(v2 = 42.212, p < 0.001). ES1 and ES2 were predictors of benignity (p < 0.01). Overall, SE was 81.8% sensitive (95% CI 64.8–92.0) and
79.1% specific (95% CI 68.3–88.4) in identifying malignancies, and 58.6% sensitive (95% CI 46.7–69.9) and 100% specific (95% CI
88.8–100) in discriminating non-neoplastic lesions. Strain ratio measurement did not improve the accuracy of qualitative elastogra-
phy. Strain ratio measurement offers no improvement over elastographic qualitative assessment of testicular lesions; testicular SE
may support conventional US in identifying non-neoplastic lesions when findings are controversial, but its added value in clinical
practice remains to be proven.
INTRODUCTION
The use of scrotal US has resulted in an increase in inciden-
tally detected non-palpable testicular lesions, with a sensitivity
ranging between 90 and 100% (Woodward et al., 2002; Appel-
baum et al., 2013). However, US differentiation between benign
and malignant testicular neoplasms and, occasionally, between
neoplastic and non-neoplastic incidental lesions is limited (Lotti
& Maggi, 2015). The ability to characterize testicular lesions
could enable the use of conservative surgery for selected cases,
especially for bilateral/multiple lesions or in monorchid patients
(Isidori et al., 2014). Until recently, all neoplastic lesions were
removed because of the assumption that they were mostly
malignant (Coret et al., 1995). Recent studies suggest that benign
tumors are much more frequent than previously thought (Isidori
et al., 2014). Several uro-andrologists have proposed a conserva-
tive approach, with close follow-up (Giannarini et al., 2010).
However, no large long-term studies are available on the follow-
up of non-operated benign testicular tumors (Toren et al., 2010).
For this reason, once malignancy has been excluded, it is useful
to establish if the lesion is non-neoplastic or is a benign tumor.
Several tools have been proposed to improve the sensitivity
and specificity of US. Contrast-enhanced ultrasound (CEUS) has
up to 93% diagnostic accuracy in the differential diagnosis of
non-palpable tumors (Isidori et al., 2014). Magnetic resonance
imaging (MRI) has also recently proved accurate in the charac-
terization of incidental testicular lesions (Gianfrilli et al., 2009;
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Dieckmann et al., 2013; Tsili et al., 2014; Manganaro et al.,
2015).
In the last few years, the US techniques strain elastography
(SE) and shear wave elastography have gained impetus as sup-
plementary, commonly available add-on tools for various appli-
cations (Itoh et al., 2006; Rago et al., 2010; Correas et al., 2013;
Cosgrove et al., 2013; Cantisani et al., 2014, 2015). These tech-
niques provide real-time non-invasive tissue characterization
performed at the same time and as an adjunct to conventional
US imaging. Shear wave elastography uses conventional ultra-
sound imaging techniques to analyze the shear waves generated
inside the human body by an ultrasound burst; the propagation
speed of the shear waves directly correlates with tissue stiffness.
Strain elastography detects local deformation (strain) under light
pressure. Its output include a color-coded representation (quali-
tative assessment) of the lesion and a semi-quantitative charac-
terization by strain ratio, calculated as the ratio of the
surrounding parenchyma to the lesions and providing a measure
of lesion stiffness. SE has been successfully used in the evalua-
tion of acute scrotal pathology (Shah et al., 2010; Patel et al.,
2014; Yusuf et al., 2015). However, to date, only a few studies
(Schurich et al., 2009; Grasso et al., 2010; Aigner et al., 2012;
Huang & Sidhu, 2012; Patel et al., 2012; Marsaud et al., 2015)
and just one prospective study (Goddi et al., 2012) have explored
the role of SE in focal testicular lesions. Furthermore, only one
retrospective study has assessed the value of strain ratio mea-
surements in neoplastic testicular lesions (Pastore et al., 2014).
Our purpose was to evaluate the accuracy of qualitative and
strain ratio elastography in the differential diagnosis of non-
palpable testicular lesions in a prospective study, including its
ability to discriminate benign from malignant tumors and its
advantages over baseline US.
MATERIALS ANDMETHODS
Study design and population
The local review board approved the protocol and all patients
gave their written informed consent. This prospective study, car-
ried out from September 2009 to September 2014, was con-
ducted at the Sapienza University, using the STARD checklist
flow diagram. From the 4615 inpatients and outpatients referred
for scrotal ultrasound, 162 were diagnosed with at least one solid
testicular lesion (inclusion criterion). Of these, 56 had a palpable
lesion and were excluded because of the high pre-test probability
of malignancy (exclusion criterion) (Isidori et al., 2014); follow-
ing surgical exploration, the lesion was confirmed as malignant
in 42/56 (75%). The remaining 106 men with incidental, non-
palpable testicular lesions were included in the study (Fig. 1).
The diagnostic protocol included routine blood tests, hor-
monal investigations, and tumor markers [human chorionic
gonadotropin (b-HCG), placental alkaline phosphatase (PLAP),
alpha-fetoprotein (a-FP), carcinoembryonic antigen (CEA),
ferritin, lactate dehydrogenase (LDH)]. Elastography was per-
formed after conventional US. Tissue-sparing surgical enucle-
ation was suggested for histological confirmation of all lesions,
as part of the protocol. All patients with solid lesions were sent
for enucleation with the awareness that some of them might
have turned out to be benign, as current guidelines do not
address the management of solid, potentially neoplastic lesions.
If the lesion was found malignant on frozen section, the
procedure was converted into a radical orchiectomy; otherwise,
the testis was left in place (tissue-sparing surgery). Compared to
other studies, the current protocol gave a higher number of his-
tologically confirmed benign lesions. Surgeons and pathologists
performed the diagnostic procedures independently of the SE
results. The primary outcome of the study was to assess the diag-
nostic accuracy of qualitative and strain ratio elastography in the
differential diagnosis of non-palpable testicular lesions. Second-
ary outcomes included the validation of previously identified risk
factors for malignancy at baseline US (Isidori et al., 2014).
Baseline US and strain elastography examination
Baseline US and SE examinations were performed using a Phi-
lips IU22 unit (Philips, Bothell, WA, USA) with a 7–15 MHz wide-
band linear transducer. Standardized protocols with axial and
transverse examinations of the lesions were performed (Oyen,
2002, Bhatt et al., 2006; American Institute of Ultrasound in M
edicine et al. 2011; Lotti et al., 2013). Two experienced sonogra-
phers (A.M.I. and C.P., both with >5 years of experience) per-
formed all US and SE examinations and stored the images and
loops for subsequent analysis by two other readers (D.G. and
V.C., both with >5 years of experience). US features were evalu-
ated according to a predefined protocol, taking into account the
most widely accepted risk factors for testicular tumors (Isidori
et al., 2014). For each lesion, the size (cm), B-mode, and color-
Doppler features were recorded and stored; the elastography set-
tings were then applied and SE images and cine-loops of each
lesion were saved for qualitative (color-coded images) and semi-
quantitative evaluation of dynamic features (strain ratio on cine-
loop). To assess the elasticity score (ES) of the lesion, the physi-
cians operated the transducer with slight pressure, maintaining
contact with skin, and perpendicular to the lesion; the testis was
held firm and stabilized with sufficient gel to achieve good US
visualization of the whole testis and avoid any loss in image
quality and artifacts.
A large elastogram region of interest (ROI) box was used to
increase the potential number of samples for a strain ratio calcu-
lation; when the compression bar visualized on the screen during
the examination to assess the quality and validity of the opera-
tor’s free hand pressure was stable for at least 5–10 sec, the oper-
ator acquired 10-sec cine-loops. Images and cine-loops were
transferred to our local picture archive system (Merge-eFilm,
Milwaukee, WI, USA) for subsequent independent analysis.
Strain elastography qualitative analysis: elasticity score (ES)
A color scale from red through green to blue is used for the
elastograms. Red indicates the highest elastic strain (softest tis-
sue) and blue indicate no strain (hardest tissue). Color-coded
elastogram images were graded visually on the stiffness of the
nodules relative to the surrounding parenchyma, assigning an
elasticity score (ES) to each image. In the absence of validated
criteria for the testes, we applied the five-point scale according
to Itoh et al. (2006), Rago et al. (2007, 2010), and Hong et al.
(2009) previously used for qualitative assessment of breast and
thyroid nodules. For completeness, sonograms were also inter-
preted in light of other published scales (Patel et al., 2012) (data
not shown). ES score data were reviewed independently for the
entire set by two physicians (D.G. and V.C.). The analyses were
performed blinded to the conclusion reached by the physician
who performed the exam (A.M.I. and C.P.) and blinded to CDU
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features or other clinical features. However, qualitative ES analy-
sis was not entirely blind to simple grayscale because the imag-
ing system used stores side-by-side grayscale US and ES images.
The elasticity scores are described in Fig. 2.
Strain elastography semi-quantitative analysis: normal tissue-
to-nodule strain ratio (SR)
Elastograms were created using QLab (Philips, Bothell, Wash).
Curves were obtained by manually locating a free ROI covering
each lesion and an identical ROI on the adjacent parenchyma.
The QLab software assesses the degree of distortion of the
nodule and surrounding tissue (strain ratio, SR). Two physicians
(G.F. and G.B.D.P.) placed the ROI and recorded the parame-
ters: for the entire set, data were collected blinded to the rest of
the exam, except for simple grayscale assessment stored simul-
taneously while acquiring ES images. The cut-off value for
strain ratio (SR) was identified using receiver operator curve
(ROC) analysis, against the reference diagnosis.
Reference standard: histology and follow-up
Tissue-sparing surgical enucleation was offered for histologi-
cal confirmation of all solid lesions. When patients declined
Figure 2 Five-point and three-point elasto-
graphic scale.
Figure 1 Flow diagram of the study.
© 2016 The Authors. Andrology published by John Wiley & Sons Ltd on behalf of American Society of
Andrology and European Academy of Andrology
Andrology, 1–11 3
STRAIN ELASTOGRAPHY OF TESTICULAR LESIONS ANDROLOGY
surgery and clinical and sonographic findings permitted a
‘watchful-waiting’ approach, follow-up was with serial US every
3 months for a minimum of 18 months, provided these patients
had a previous negative point-of-diagnosis CT or MR examina-
tion confirming absent abdominal lymph nodes and a normal
chest X-ray or CT.
In the reference diagnosis, we interpreted as non-malignant
any lesions histologically confirmed or showing resolution, no
growth, no tumor marker rises, or other relevant clinical events
at repeated follow-up (stable on ≥6 consecutive scans); among
these, we considered all single, entirely solid, hypoechoic lesions
with internal vascularization that maintained similar grayscale
features and a preserved internal vascularization over time (at
least 18 months) as benign neoplasms (stromal tumors). In
contrast, any multiple and/or non-vascularized lesions were
interpreted as non-neoplastic (Leydig cell hyperplasia, segmen-
tal ischemia, fibrosis, cysts) according to a protocol validated by
prior histological, CEUS, and MRI published studies (Isidori
et al., 2014; Manganaro et al., 2015). Whenever possible,
intraoperative frozen section examination (FSE) was performed
during surgery (61/64) (Isidori et al., 2014).
Malignant tumors underwent molecular characterization per-
formed by a biologist (F.B., Ph.D. with >6 years’ experience in
molecular biology). Cytokeratin, beta-human chorionic gonado-
tropin (b-HCG), placental alkaline phosphatase (PLAP), and
alpha-fetoprotein (a-FP) were tested.
Statistical analysis
Independent groups were compared by Mann–Whitney test
for continuous variables or odds ratio (OR) confidence intervals
for categorical variables. Reliability analysis for qualitative and
semi-quantitative parameters was performed by analysis of the
intraclass correlation coefficients. Relationships between the
qualitative data were examined by chi-square test or Fisher’s
exact tests. The risk of malignancy was evaluated by binary logis-
tic regression analysis. Receiver operating characteristic (ROC)
curve analysis was applied to calculate the cut-off values of SR,
through Youden index (J). Sensitivity (SE), specificity (SP), posi-
tive predictive value (PPV), and negative predictive value (NPV)
of qualitative elastography and strain ratio values were calcu-
lated using ROC curves with DeLong’s method (DeLong et al.,
1988). Statistical analyses were performed by SPSS 17.0 (Chicago,
IL, USA) using two-tailed significance tests and MEDCALC (12.7.0.0,
Ostend, Belgium), with p ≤ 0.05 considered statistically
significant.
RESULTS
Clinical data
Patients were referred for infertility (43/106, 40.6%), screening
during andrological prevention campaigns for young men in
high schools and universities (21/106, 19.8%), follow-up of a con-
tralateral or ipsilateral tumor (13/106, 12.3%), testicular pain (11/
106, 10.4%), varicocele (10/106, 9.4%), Klinefelter’s syndrome (5/
106, 4.7%), follow-up for microlithiasis (2/106, 1.9%), and detec-
tion of elevated levels of alpha-fetoprotein (1/106, 0.9%).
Overall, a histological diagnosis was performed for 64 patients
following enucleation (n = 28) or total orchiectomy (n = 36) per-
formed by a single surgeon (G.F., with >20 years’ experience in
andrological surgery). Based on the definitive histology and the
long-term follow-up of non-operated lesions, 37 of the 106 study
subjects had malignant tumors, 38 benign tumors, and 31 non-
neoplastic lesions. Leydig cell tumors were the most frequent
benign tumors (20/38, 18.9% of the entire set) (Table 1). Malig-
nancies were diagnosed by enucleation in 4/37 cases (three
seminomas removed from three monorchid patients for a con-
tralateral tumor plus one atypical Leydig cell tumor), by enucle-
ation followed by orchiectomy in 32 cases, and during follow-up
in one case (metastatic embryonal carcinoma). Benign lesions
(both neoplastic and non-neoplastic) were diagnosed by enucle-
ation in 24/69 cases, by orchiectomy in three cases (two Leydig
cell tumors and one granulomatous orchitis), or because of lack
of change during follow-up (42 cases). Malignancies tended to
be larger than benign tumors (median, interquartile range: 1.2,
0.6–1.5 vs. 0.5, 0.4–0.7, p < 0.001). Groups were not statistically
different for age, hormones, or reason for referral. Testicular vol-
umes were in the lower range (right testicular volume: median,
interquartile range: 11.2, 8.1–16.5; left testicular volume: median,
interquartile range: 11.7, 8.0–15.9).
Tumor markers were normal in all patients except one who
was referred because of marginally elevated a-FP levels (which
were normal when repeated) and one with embryonal
Table 1 Clinical data (median and interquartile range) of all patients and lesions according to the reference diagnosis
Final diagnosis n Age (years) Diameter (cm) Testicular volume (mL)
R L
All patients 106 34.5 (28–41.2) 0.6 (0.5–1.0) 11.2 (8.1–16.5) 11.7 (8.0–15.9)
Malignant tumors 37 35 (29–40.5) 1.2 (0.6–1.5)* 12.0 (9.1–16.7) 12.4 (8.1–16.7)
Pure seminoma 33 36 (29.5–41) 1.2 (0.6–1.5) 11.9 (9.1–16.0) 13.3 (8.1–17.1)
Leydig cell tumor, high gradea 1 33 0.5 14 12
Embryonal carcinoma 3 26 (23–26) 1.5 (1.0–1.5) 19.0 (7–19.0) 8.6 (8–8.6)
Benign tumors 38 34.5 (29.7–42) 0.5 (0.4–0.7) 9.0 (6.7–13.6) 9.2 (6.9–14.5)
Leydig cell tumor 20 39.5 (28.7–42) 0.55 (0.5–0.76) 8.6 (5.2–13.2) 7.9 (4.9–13.8)
Sertoli cell tumor 1 34 0.6 14.3 15.7
Epidermoid cyst 2 21 (19–21) 1.3 (1.3–1.35) 17.2 (14–17.2) 17.6 (14–17.6)
Histology not available 15 34 (30–42) 0.45 (0.4–0.57) 9.0 (6.1–12.6) 9.0 (7.9–13.4)
Non-neoplastic lesions 31 34 (27–44) 0.5 (0.4–0.8) 12.7 (8.6–18.9) 12.0 (9.0–17.2)
Granulomatous orchitis 1 25 1.5 – 17.5
Histology not available 30 34 (27–44) 0.5 (0.4–0.8) 12.7 (8.6–18.9) 12.0 (9.0–17.2)
*p < 0.001 malignant tumors vs. benign tumors. aHigh-grade Leydig cell tumor was included in the malignant neoplastic lesions group because of a higher mitotic
index and higher MIB-1 activity (relative to the Leydig cell tumors included in the benign neoplastic lesions group); n, number.
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carcinoma who had normal tumor markers at baseline SE exam-
ination, but showed raised a-FP levels three months later.
Baseline ultrasound
This was the first US examination for 93/106 patients. The
remaining 13 had undergone previous testicular surgery: eight
had undergone previous orchiectomy with the incidental lesion
present in the remaining testis, while the remainder (n = 5) had
undergone enucleation for ipsilateral or contralateral neoplasm.
At baseline US, marked hypoechogenicity was found in 36/37
malignant lesions (97.3%), in 28/38 benign tumors (73.7%,
p = 0.018, OR = 2.554), and in 17/31 of non-neoplastic lesions
(54.8%, p = 0.002, OR = 3.389). A total of 35.1% (13/37) malig-
nant lesions showed irregular margins, compared to 18.4% (7/
38, p = 0.106) of benign tumors and 6.5% (2/31, p = 0.02) of
non-neoplastic lesions. Microlithiasis was significantly associ-
ated with malignancy (21/37 vs. 7/69, p < 0.001, OR 2.453).
Internal vascularization was common in both benign and
malignant tumors (28/38 vs. 32/37, p = 0.172), but was seen in
only 3/31 of the non-neoplastic lesions (9.7%, p < 0.001 com-
pared to malignancies). The two atypical epidermoid cysts and
3/37 malignant lesions (two embryonal carcinomas and one
seminoma) had intratumoral calcifications (Table S1). Logistic
analysis revealed that independent risk factors for malignant
tumors were as follows: size (OR 17.788; p = 0.002), parenchy-
mal microlithiasis (OR 17.673, p < 0.001), intralesional vascular-
ization (OR 9.207, p = 0.006), and hypoechogenicity (OR,
11.509, p = 0.036). In contrast, when combining benign and
malignant tumors (compared to non-neoplastic lesions),
parenchymal microlithiasis (OR 4.543, p = 0.003) and intrale-
sional vascularization (OR 37.083 p < 0.001) were independent
risk factors, confirming previous data (Oyen, 2002; Bushby
et al., 2007; Isidori et al., 2014; Lock et al., 2014; Maturen, 2015;
Richenberg et al., 2015) and validating that the current series
was representative.
The diagnostic performance of conventional US is reported in
Table 2.
Strain elastography qualitative analysis: elasticity score (ES)
Under the five-point scale developed by Itoh, 39/106 lesions
scored IV (36.8%), five scored III (4.7%), 48 scored II (45.3%), and
14 scored I (13.2%). The degree of agreement among measure-
ments from the two operators was high: there was 100% agree-
ment for scores I, II, and V and three discrepancies for scores III
and IV (D.G. attributed a score of III to two nodules which were
scored IV by V.C. and D.G. attributed a score of IV to one nodule
that V.C. scored III). No lesion in our series received a score of V
and only 4.7% a score of III, therefore, we simplified Itoh classifi-
cation to a three-point scale and performed subsequent analysis
based on this criteria: ES1 (Fig. 3) and ES2 (Fig. 4) corresponded
to Itoh scores I and II, respectively, while ES3 (Fig. 5) aggregated
Itoh scores III to V (Fig. 2). Overall, a higher elasticity score was
associated with malignant tumors (v2 = 37.675 p < 0.001) or
tumors in general (v2 = 32.877 p < 0.001); of the 37 malignant
nodules, 30 were scored ES3 (81.1%, v2 = 36.660 p < 0.001 com-
pared to all benign lesions). The remaining malignancies were
scored ES2 (7/37, 18.9%, v2 = 15.945 p < 0.001).
Of the benign neoplastic lesions, 14/38 were scored ES3
(36.8%, v2 = 15.130 p < 0.001 compared to malignant lesions),
19/38 ES2 (50%, v2 = 7.996, p = 0.005), and 5/38 ES1 (13.2%,
v2 = 5.216 p = 0.054).
None of the non-neoplastic lesions were scored ES3, 22/31
were scored ES2 (71%, v2 = 11.665, p = 0.001, compared to all
neoplasms), and 9/31 ES1 (29%, v2 = 11.665, p = 0.002)
(Table 3).
When comparing malignant tumors vs. all benign lesions (be-
nign neoplastic and non-neoplastic together), none of the malig-
nant tumors scored ES1, while 7/37 scored ES2 vs. 41/69 benign
lesions (18.9% vs. 59.4%, OR = 1.837, p < 0.001), indicating
that ES1 and ES2 were predictive of benignity. Logistic regres-
sion analysis revealed a significant association between ES3 and
malignancy (v2 = 42.212, n = 106, df = 2, p < 0.001, Nagelkerke
R2 = 0.453), as well as the likelihood of a lesion being neoplastic
(v2 = 43.661, n = 106, df = 2, p < 0.001, Nagelkerke R2 = 0.481).
Given these results, nodules scored as ES1 or ES2 were classified
as probably benign (neoplastic or non-neoplastic), while nod-
ules scored as ES3 were classified as probably malignant. This
classification was then compared with the reference diagnosis
for calculation of diagnostic accuracy. The diagnostic perfor-
mance of SE is reported in Table 2.
Strain elastography semi-quantitative analysis: normal tissue-
to-nodule strain ratio (SR)
The absolute agreement among SR measurements was 0.961
for average measures (95% CI 0.934 to 0.988). Given the substan-
tial reliability, data obtained by a single operator were used.
Malignant lesions showed higher SR values than benign
lesions (median, interquartile ranges 1.48, 1.18–1.84 vs. 1.25,
1.00–1.51) (p < 0.013). Neoplasms (median, interquartile ranges
1.37, 1.10–1.70) showed higher SR values than non-neoplastic
lesions (1.11, 0.97–1.59) (p = 0.023). There was a difference when
comparing non-neoplastic lesions with malignancies
(p = 0.008), but no difference between benign neoplastic lesions
with malignancies (p = 0.089) or benign tumors and non-neo-
plastic lesions (p = 0.175) (Table 4). Using ROC curve analysis,
we estimated an internal, system-specific cut-off for SR of >1.41
for discriminating benign from malignant lesions (AUC 0.631,
95% CI 0.531–0.722, Youden index 0.2613) and >1.19 for
Table 2 Diagnostic performance of plain US, qualitative and strain elastography values. Data are presented as percentage (95% CI)
Qualitative
and
strain
elastography
Benign vs. malignant Neoplastic vs. non-neoplastic
SE SP PPV NPV AUC SE SP PPV NPV AUC
US 89.2 (74.6–97.0) 85.5 (75.0–92.8) 76.7 (61.4–88.2) 93.7 (84.5–98.2) 0.878 94.6 (86.9–98.5) 87.1 (70.2–96.4) 94.7 (86.9–98.5) 87.1 (70.2–96.4) 0.910
ES 81.1 (64.8–92.0) 79.7 (68.3–88.4) 68.2 (52.4–81.4) 88.7 (78–95) 0.804 58.7 (46.7–69.9) 100 (88.8–100) 100 (91.8–100) 50 (32.9–61.5) 0.793
SR 59.4 (42.1–75.2) 66.6 (54.3–77.6) 48.9 (33.7–64.2) 75.4 (62.6–85.6) 0.631 69.3 (57.6–79.5) 61.3 (42.2–78.2) 81.2 (69.5–89.9) 45.2 (29.8–61.3) 0.653
ES score, elasticity score (elasticity score 3 vs. combined elasticity score 1 and 2); SR, strain ratio; SE, sensitivity; SP, specificity; PPV, positive predictive value; NPV, nega-
tive predictive value; AUC, area under the curve.
© 2016 The Authors. Andrology published by John Wiley & Sons Ltd on behalf of American Society of
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discriminating neoplastic from non-neoplastic lesions (AUC
0.653, 95% CI 0.554–0.743, Youden index 0.3062) (Table 2).
Pairwise comparison of ROC curves showed that strain ratio
analysis was significantly worse than qualitative assessment in
diagnosing malignancies (p = 0.003, ES AUC 0.804, 95% CI
0.716–0.875 vs. SR AUC 0.631, 95% CI 0.531–0.722), as well as
in identifying non-neoplastic lesions (p = 0.011, ES AUC
0.793, 95% CI 0.704–0.866 vs. SR AUC 0.653, 95% CI 0.554–
0.743).
COMPARISON OF IMAGING TECHNIQUES
In the diagnosis of malignant vs. non-malignant lesions, base-
line US was 89.2% sensitive and 85.5% specific for malignancy,
compared with 81.1% and 79.7% for real-time elastography.
Baseline US was therefore more accurate than elastography as a
standalone procedure for the diagnosis of malignancies. Analyz-
ing elastography in light of grayscale findings, we found that ES
identified as malignant (ES3) three cases that were erroneously
considered benign by US (three false negative US findings). Most
importantly, ES correctly identified as benign (ES1 and ES2) five
lesions that US considered suspicious for malignancies (two Ley-
dig cell tumors, one granulomatous orchitis and two areas of
fibrosis; five false-positive US findings). None of the malignant
tumors scored ES1. In contrast, elastography misinterpreted nine
lesions as potentially malignant (ES3) that were correctly identi-
fied as benign by US (two epidermoid cysts, six Leydig cell
tumors, one Sertoli cell tumor) and six seminomas as potentially
benign (ES2), which, conversely, were correctly identified at US.
In summary, a finding of ES1 can be used to increase the speci-
ficity of US by excluding cases of suspected malignancy.
In the diagnosis of neoplastic vs. non-neoplastic lesions, none
of the non-neoplastic lesions scored ES3 (100% specificity),
against 87.1% specificity for conventional US. Analyzing elastog-
raphy in light of grayscale findings, ES correctly identified as
non-neoplastic: one granulomatous orchitis identified as suspi-
cious for malignancy on US as well as two areas of fibrosis and
one Leydig cell hyperplasia identified as neoplastic on US (four
false positives on US). However, US was much more sensitive
(94.6%) than SE (58.7%).
In general, SE offered an advantage in lesions (granulomatous
orchitis, areas of fibrosis, burn-out tumors) where US color-
Doppler findings were equivocal.
Finally, to test whether ES2 was typically associated with
benign tumors, we analyzed the distribution of ES appearance in
Leydig cell tumors. We found that five were ES1 (13.2%), 19 were
ES2 (50.0%), and 12 were ES3 (36.8%), suggesting no discrimina-
tory value for the identification of Leydig cell tumors.
DISCUSSION
The normal testis demonstrates a homogeneous medium
hardness at elastography (Jedrzejewski et al., 2013) (Fig. 6).
Focal lesions can often be recognized as harder than the
(A)
(B)
(C)
(D)
Figure 3 Baseline US and qualitative elastogra-
phy of soft lesions (ES1). In panel (A) and (D),
are described respectively, a Leydig cell hyper-
plasia (at histology) and a fibrotic lesion (stable
at 48-months follow-up); panel (B) and (C)
show two hypoechoic lesions, resulted both
Leydig cell tumor at histology.
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surrounding testicular tissue, with some important exceptions
reported with hematomas or mixed fluid lesions (Patel et al.,
2014; Yusuf et al., 2015). Normal testis parenchyma is hard,
but compared with the even harder solid tumorous tissue, it
has a relatively softer appearance, displaying areas of green
and light blue (Jedrzejewski et al., 2013). Elastography has
proven useful for studying focal lesions in various organs
(Brock et al., 2012; Cosgrove et al., 2013; Cantisani et al.,
2015) and a possible role in the diagnosis of focal testicular
lesions was recently advocated. Schurich et al., (2009)
described the value of SE in 20 testicular lesions, showing that
elastography improved the detection of testicular masses, and
reported that all tumors were hard (n = 15). Conversely,
Grasso et al., (2010) found SE unreliable when used alone to
discriminate malignant from benign lesions. Goddi et al.
(2012) performed the only large prospective study: the authors
analyzed 144 lesions in 88 testes using the five-point score
suggested by Itoh et al. for breast disease (Itoh et al., 2006),
and concluded that SE had a diagnostic accuracy of 95.8% in
differentiating malignant from all other lesions, reaching
98.8% in lesions smaller than 5 mm. A hard lesion score (ES
>4) was observed in 87.5% of malignancies, but the prevalence
of histologically proven malignant tumors in their series was
low (22%) and the number of very small lesions (<5 mm) was
high (Goddi et al., 2012).
In the same year, Aigner et al. retrospectively analyzed 50
patients, of whom, 34 had tumors and 16 non-neoplastic lesions
(Aigner et al., 2012). They differentiated soft from hard lesions
using a two-point score, and found that all 34 testicular tumors
were hard on SE (13 seminomas, two embryonal carcinomas,
nine mixed germ cell tumors, one teratoma, four Leydig cell
tumors, three Sertoli cell tumors, one metastasis, and one epi-
dermoid cyst), demonstrating a sensitivity of 100% and an accu-
racy of 94% in diagnosing a testicular tumors in general.
Marsaud et al. found high sensitivity (96%) but low specificity
(37.5%) for strain ratio (Marsaud et al., 2015), while Pastore et al.
suggested that strain ratio measurement may provide additional
objective information to support the algorithm used to diagnose
testicular lesions (Pastore et al., 2014). It is worth noting that in
all these studies, the number of benign stromal neoplasms (Ley-
dig cell or Sertoli cell tumors) was low.
Given the conflicting results, we carried out a prospective study
to evaluate the application of qualitative and strain ratio elastog-
raphy in non-palpable testicular lesions. These are the most chal-
lenging lesions, as the larger the lesion, the higher the likelihood
of malignancy. In this context, we demonstrated that the color-
coded SE classification initially developed for breast lesions and
often also used for other endocrine parenchymas (e.g. thyroid),
could be simplified into a three-point scale when evaluating the
testis. For most other tissues, scores 1 and 2 are generally
(A)
(B)
(C)
(D)
Figure 4 Baseline US and qualitative elastogra-
phy of intermediate stiff lesions (ES2). Figure 4
shows four lesions, scored ES2 at elastography.
Both lesions in panel (A) and (B) resulted Leydig
cell tumors at histology, while the lesion in panel
(C) resulted a seminoma at histology. In panel
(D), the heterogeneous hypoechoic lesion was
diagnosed as a testicular hematoma after
18 months of clinical and US follow-up.
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considered suggestive of benignity, score 3 as an indeterminate/
ambiguous lesion, and score 4 and 5 suggestive of malignancy.
However, the histological structure of testicular parenchyma is
very different from that of breast tissue: it is muchmore homoge-
neous, compact, and stable, and therefore easier to assess. In
fact, we found that the scores were distributed mainly into three
groups. Given this, and in light of the pathology and epidemio-
logical considerations, we thought it appropriate to simplify the
scale to a more operator-friendly three-point scale. Score 1 was
assigned to features suggestive of benignity (high elasticity),
score 2 to ambiguous features (in which color distribution pat-
tern was difficult to interpret), and score 3 to nodules with a neat
hard core typical of malignant features (low elasticity).
Most tumorous lesions (benign and malignant) in our series
were hard on qualitative elastography (ES3), probably because
neoplasms present high cellularity. Half of the benign tumors
were scored as 2 (p = 0.005, Fig. 5), while malignant tumors
were mostly completely hard lesions (ES3, 81.1%, p < 0.001).
Benign and malignant neoplasms thus show a certain overlap in
hardness that does not allow a sufficiently confident differential
(A)
(B)
(C)
(D)
(E)
(F)
Figure 5 Baseline US and qualitative elastogra-
phy of hard lesions (ES3). Panel (A–F) show six
markedly hypoechoic lesions, scored ES3 at elas-
tography (hard lesions) that resulted Leydig cell
tumor (A–C) and seminomas (D–F) at definitive
histology.
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diagnosis (e.g. epidermoid cysts) (Patel et al., 2012). In contrast,
our three-point score color-coded classification was significantly
helpful in discriminating between malignant tumors (ES3) and
non-neoplastic lesions (ischemia, abscesses, non-tense cysts),
which present as soft (ES1) or intermediate stiff (ES2) lesions. In
fact, only neoplastic lesions were scored as ES3, with 100% PPV
(against combined ES1 and ES2). Abscesses, partial infarction,
Leydig cell hyperplasia, fibrosis and non-tense cysts were all soft
on elastography.
Application of elastography to parenchymal cysts remains
controversial: even if SE does not confer any benefit in thyroid
cyst assessment, it has been found of some advantage in the
differential diagnosis of breast cysts (Gheonea et al., 2011). Its
application to testicular cysts has not yet been validated,
although the inclusion of small, non-tense cysts that were
hypo- or anechoic on grayscale US is an advantage of the cur-
rent series. However, we did not achieve the high sensitivity
reported in the previously published articles, and specifically,
ES was neither superior to US in diagnosing malignancies
(81.1% for ES vs. 89.2% for US, p = 0.153) nor in diagnosing
neoplasms (58.7% for ES vs. 94.6% for US, p = 0.009). Given
these results, we are not confident in suggesting the use of elas-
tography as a standalone procedure. However, a maximum
hardness score (ES3) was 100% specific in excluding non-neo-
plastic lesions compared to 87.1% for baseline US. In addition,
although a score of ES1 was uncommon (13%) in our series,
none of the malignant tumors was ES1; therefore, in doubtful
cases, an elastography score of ES1 could allow a careful
‘watchful-waiting’ approach.
Analysis of individual cases revealed that US accuracy dropped
when CDU findings were equivocal. The lack of flow does not
eliminate the possibility of neoplasm; for example, in our study,
the most challenging cases were burned-out tumors or very
rapidly aggressive histotypes, in which internal flow was absent
or presented as just a perilesional rim. This appearance, how-
ever, is also common to some ischemic/post-traumatic changes,
atypical epidermoid cysts, and granulomas. In these cases, ES
proved useful. In summary, a score of ES3 could reinforce the
US diagnosis in suggesting the neoplastic nature of the lesion,
while conversely, ES1 could reasonably exclude a malignant
lesion (but not a benign tumor).
Another novelty of our work was the evaluation of strain ratio
obtained by dividing the reference tissue by the lesion strain.
Our study is one of the first to investigate the role of SR in dis-
criminating malignancies from benign lesions. Unlike the study
by Pastore et al. (Pastore et al., 2014), we found that SR mea-
surement did not provide significant information and showed
lower sensitivity and specificity in the differential diagnosis of
testicular lesions than the score classification system.
Our study has several advantages compared to the previous
ones, as it is prospective, large, and with a varied case mix,
but it also has some limitations. First, the degree of tissue
compression influences the elasticity image and, conse-
quently, the elasticity score; it takes some practice to be able
to exert correct pressure to obtain suitable images for elastic-
ity analysis. Second, SR is a measure of relative stiffness
between healthy parenchyma and a nodule. The tissue adja-
cent may not be normal (e.g. in patients with Klinefelter’s
syndrome), which could theoretically alter the measurements.
Third, the strain ratio is dependent on the manufacturer of
Table 3 Frequencies of elasticity scores (ES). Data are presented as percentages (number)
Final
diagnosis
n Malignant
tumors
Benign
tumors
M vs. B All neoplastic
lesions (B and M)
Non-neoplastic
lesions
N vs. NN All benign
lesions (N and NN)
M vs. ABL
All patients, n 106 37 38 75 31 69
ES1 14 0.0 (0) 13.2 (5) 0.050 6.7 (5) 29.0 (9) 0.002 20.3 (14) 0.002
ES2 48 18.9 (7) 50.0 (19) 0.005 34.7 (26) 71.0 (22) 0.001 59.4 (41) <0.001
ES3 44 81.1 (30) 36.8 (14) <0.001 58.7 (44) 0.0 (0) <0.001 20.3 (14) <0.001
ES1, elasticity score 1; ES2, elasticity score 2; ES3, elasticity score 3; n, number; M, malignant tumors; B, benign tumors; N, neoplastic lesions (all tumors); NN, non-
neoplastic lesions; ABL, all benign lesions (neoplastic and non-neoplastic).
Table 4 Strain ratio values of elastograms reported in absolute values (median and interquartiles) for malignant vs. benign tumors, neoplastic vs. non-neo-
plastic lesions, and all benign lesions
Final
diagnosis
n Malignant tumors Benign tumors M vs. B All neoplastic
lesions (B and M)
Non-neoplastic
lesions
N vs. NN All benign
lesions (N and NN)
M vs. ABL
All patients, n 106 37 38 75 31 69
SR 1.48 (1.18–1.84) 1.32 (1.07–1.48) 0.089 1.37 (1.10–1.70) 1.11 (0.97–1.59) 0.023 1.25 (1.00–1.51) 0.013
SR, strain ratio; n, number; M, malignant tumors; B, benign tumors; N, neoplastic lesions (all tumors); NN, non-neoplastic lesions; ABL, all benign lesions (neoplastic
and non-neoplastic).
Figure 6 Normal testis parenchyma at elastography. Normal testis par-
enchyma at elastography, shaded in green and blue, showing an intermedi-
ate elasticity.
© 2016 The Authors. Andrology published by John Wiley & Sons Ltd on behalf of American Society of
Andrology and European Academy of Andrology
Andrology, 1–11 9
STRAIN ELASTOGRAPHY OF TESTICULAR LESIONS ANDROLOGY
the elastography unit. Our software provides SR measure-
ments automatically, but it is possible that different software
on other US systems could provide different values. Fourth,
ES was evaluated blinded to CDU and real-time US examina-
tion, but not to simultaneous simple grayscale imaging. How-
ever, although this might not be a perfect blinding, in real
life, ES will always be performed after baseline US, and there-
fore, we believe that this limitation does not affect the validity
of our conclusion, which is to suggest that ES be added on to
baseline US. Finally, there could be some selection bias as
half of our patients were referred for infertility screening;
however, infertile patients are those at highest risk of testicu-
lar cancer, so they are the ideal population to test this new
diagnostic tool.
In conclusion, the results of our study place SE into context for
the evaluation of incidental testicular lesions, highlighting its
role, and limitations, and validating a more practical scoring sys-
tem. We conclude that qualitative assessment in conjunction
with a careful clinical history and supplementary diagnostic
evaluation could be helpful in differentiating non-palpable tes-
ticular malignancies from non-neoplastic lesions in challenging
cases, but it cannot be used to discriminate benign from malig-
nant neoplasms. This work supports the need for a multimodal-
ity approach combining different techniques (grayscale US,
CDU, ES, CEUS, MRI) to achieve the highest diagnostic accuracy
in the characterization of testicular masses.
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